The cardio-renal-anaemia syndrome predicts survival in peritoneally dialyzed patients

Archives of Medical Science

Volumn 6, Issue 4, 2010, Pages 539-544

  Malyszko, Jolanta ^a   Zbroch, Edyta ^a   Malyszko, Jacek ^a   Mysliwiec, Michal ^a   Iaina, Adrian ^b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b APC Health Specialists Clinics   (Israel)

Author keywords

Anaemia; Chronic heart failure; Diabetes; Elderly; Peritoneal dialysis

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; PROTEIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; CALCIUM BLOOD LEVEL; CARDIO RENAL ANAEMIA SYNDROME; CORRELATION ANALYSIS; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE SEVERITY; ERYTHROCYTE COUNT; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INJURY SCALE; IRON BLOOD LEVEL; KAPLAN MEIER METHOD; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PERITONEAL DIALYSIS; PHOSPHATE BLOOD LEVEL; SURVIVAL RATE; THROMBOCYTE COUNT; TREATMENT OUTCOME;

EID: 77956852949     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2010.14465     Document Type: Article

References (31)

1. US Renal Data System: USDRS 2008 Annual Data Report. Bethesda, MD. National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2009. Available at: www.usrds.org.
2. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. Am J Kidney Dis 1996; 28: 53-61. (Pubitemid 26231466)
3. Sarnak MJ, Levey AS, Schoolwerth AC, et al.; American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovacular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154-69.
4. Stack AG, Bloembergen WE. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. Am J Kidney Dis 2001; 38: 992-1000.
5. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 1995; 47: 884-90.
6. Trespalacios FC, Taylor AJ, Agodoa LY, Bakris GL, Abbott KC. Heart failure as a cause for hospitalization in chronic dialysis patients. Am J Kidney Dis 2003; 41: 1267-77.
7. Levin A. Anemia and left ventricular hypertrophy in chronic kidney disease populations: a review of the current state of knowledge. Kidney Int Suppl 2002; 80: 35-8.
8. Felker GM, Adams KF Jr, Gattis WA, O'Connor CM. Anemia as a risk factor and therapeutic target in heart failure. J Am Coll Cardiol 2004; 44: 959-66.
9. Al-Ahmad A, Rand WM, Manjunath G, et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001; 38: 955-62.
10. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 2003; 107: 223-5.
11. Silverberg DS, Wexler D, Blum M, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 2000; 35: 1737-44.
12. Silverberg DS, Wexler D, Iaina A, Steinbruch S, Wollman Y, Schwartz D. Anemia, chronic renal disease and congestive heart failure - the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists. Int Urol Nephrol 2006; 38: 295-310. (Pubitemid 44138158)
13. Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 2005; 16: 489-95.
14. Li S, Foley RN, Collins AJ. Anemia and cardiovascular disease, hospitalization, end stage renal disease, and death in older patients with chronic kidney disease. Int Urol Nephrol 2005; 37: 395-402.
15. Silverberg DS, Wexler D, Iaina A, Steinbruch S, Wollman Y, Schwartz D. Anemia, chronic renal disease and congestive heart failure - the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists. Int Urol Nephrol 2006; 38: 295-310.
16. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B. The severe cardiorenal syndrome: "Guyton revisited". Eur Heart J 2005; 26: 11-7.
17. Ishani A, Weinhandl E, Zhao Z, et al. Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2005; 45: 391-9.
18. van der Meer P, Lipsic E, Westenbrink BD, et al. Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure. Circulation 2005; 112: 1743-7.
19. Anand IS. Anemia and chronic heart failure implications and treatment options. J Am Coll Cardiol 2008; 52: 501-11.
20. Silverberg DS, Wexler D, Blum M, et al. The interaction between heart failure, renal failure and anemia-the cardiorenal anemia syndrome. Blood Purif 2004; 22: 277-84.
21. Silverberg DS, Wexler D, Iaina A. The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron? J Nephrol 2004; 17: 749-61.
22. Wexler D, Silverberg DS, Sheps D, et al. Prevalence of anemia in patients admitted to hospital with a primary diagnosis of congestive heart failure. Int J Cardiol 2004; 96: 79-87. (Pubitemid 38760242)
23. Silverberg DS, Wexler D, Palazzuoli A, Iaina A, Schwartz D. The anemia of heart failure. Acta Haematol 2009; 122: 109-19.
24. Iaina A, Silverberg DS, Wexler D, Iaina Nomy L. The cardiorenal anemia syndrome. Med Pregl 2007; 60 Suppl 2: 145-50.
25. Palazzuoli A, Gallotta M, Iovine F, Nuti R, Silverberg DS. Anaemia in heart failure: a common interaction with renal insufficiency called the cardio-renal anaemia syndrome. Int J Clin Pract 2008; 62: 281-6.
26. Silverberg DS, Wexler D, Blum M, Schwartz D, Wollman Y, Iaina A. Erythropoietin should be part of congestive heart failure management. Kidn Int Suppl 2003; 87: S40-7.
27. Hunt SA, Abraham WT, Chin et al.; American College of Cardiology Foundation; American Heart Association. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009; 53: e1-90.
28. Moretta G, Locatelli AJ, Gadola L, et al. Rio de La Plata study: a multicenter, cross-sectional study on cardiovascular risk factors and heart failure prevalence in peritoneal dialysis patients in Argentina and Uruguay. Kidney Int Suppl 2008; 108: S159-64.
29. Collins AJ, Vassalotti JA, Wang C, et al. Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease. Am J Kidney Dis 2009; 53 (3 Suppl 3): S71-7.
30. Arima H, Nakamoto H, Okada S, et al. Risk factors for vascular complications in patients on peritoneal dialysis. Adv Perit Dial 2006; 22: 192-7.
31. Enríquez J, Bastidas M, Mosquera M, et al. Survival on chronic dialysis: 10 years' experience of a single Colombian center. Adv Perit Dial 2005; 21: 164-7.